Not available
Quote | Teva Pharmaceutical Industries Limited American Depositary Shares (NYSE:TEVA)
Last: | $16.55 |
---|---|
Change Percent: | 0.43% |
Open: | $16.27 |
Close: | $16.55 |
High: | $16.62 |
Low: | $16.1 |
Volume: | 7,736,965 |
Last Trade Date Time: | 07/02/2024 03:00:00 am |
News | Teva Pharmaceutical Industries Limited American Depositary Shares (NYSE:TEVA)
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press release on its second quarter 2024 financial results on Wednesday, July 31, 2024, at 7:00 a.m. ET. Following the release, Teva will conduct a conference call and live webcast on the same day, at 8...
2024-07-01 10:22:31 ET More on Teva Pharmaceutical Teva Pharmaceutical: Buy This Bargain Before It's Gone Teva to pay $750M as part of tax deal with Israel Teva Pharmaceutical Industries Limited (TEVA) Goldman Sachs 45th Annual Global Healthcare Conference (Transcrip...
Message Board Posts | Teva Pharmaceutical Industries Limited American Depositary Shares (NYSE:TEVA)
Subject | By | Source | When |
---|---|---|---|
MomentumIts trading | JLS | investorshub | 05/08/2023 9:55:40 PM |
$TEVA The trading | Zilla | investorshub | 05/08/2023 8:56:28 PM |
and the shorts continue | Tigerbalsam | investorshub | 05/08/2023 3:10:48 AM |
Time for a bounce? | JLS | investorshub | 05/06/2023 5:42:43 PM |
$TEVA good read | WovenO2 | investorshub | 05/06/2023 3:13:04 PM |
News, Short Squeeze, Breakout and More Instantly...
Teva Pharmaceutical Industries Limited American Depositary Shares Company Name:
TEVA Stock Symbol:
NYSE Market:
Teva Pharmaceutical Industries Limited American Depositary Shares Website:
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press release on its second quarter 2024 financial results on Wednesday, July 31, 2024, at 7:00 a.m. ET. Following the release, Teva will conduct a conference call and live webcast on the same day, at 8...
4th interim analysis of PEARL real world migraine prevention study presented at 10th European Association of Neurology (EAN) congress in Helsinki New sub-analysis of PEARL data highlights potential negative impact of treatment pauses on patient outcomes 1 Sub-analysis explorin...
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it has entered an agreement with the Israel Tax Authority (the "ITA") resolving all pending litigation with respect to taxes payable for the Company's taxable years 2008-2020. Under the terms of the agreement the Compa...